Cellectis SA (CLLS)

4.18 +0.20 (+5.03%) USD  |  NASDAQ  |  Feb 25, 16:00
4.24 +0.06 (+1.44%) After-Hours: 20:00
More

Cellectis Stock Based Compensation (Annual)

Stock Based Compensation (Annual) Chart

View Stock Based Compensation (Annual) for CLLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Annual) Range, Past 5 Years

View Stock Based Compensation (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Annual) Benchmarks

View Stock Based Compensation (Annual) Benchmarks
Start Trial
EDAP TMS SA Upgrade
DBV Technologies SA Upgrade
Ascendis Pharma A/S Upgrade
Akari Therapeutics Plc Upgrade
Biodexa Pharmaceuticals Plc Upgrade